PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department for Medicine (Gastroenterology, Infectious diseases, Rheumatology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.\', \'Clinician Scientist Program, Berlin Institute of Health, Berlin, Germany.\', \'Deutsches Rheumaforschungszentrum Berlin (DRFZ), An Institute of the Leibniz Association, Berlin, Germany.\', \'Department for Medicine (Gastroenterology, Infectious diseases, Rheumatology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany. britta.siegmund@charite.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41385-021-00384-9
?:hasPublicationType
?:journal
  • Mucosal immunology
is ?:pmid of
?:pmid
?:pmid
  • 33608656
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.314
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19-from mucosal immunology to IBD patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all